-
Withdrawal of statin therapy in acute ischemic stroke may lead to increases in death and disability.
-
Phrenic nerve conduction studies may be a promising method to anticipate respiratory failure in patients with GBS.
-
Critically ill emergency department patients with a ≥ 6 hour delay in ICU transfer had an increased hospital length of stay and higher ICU and hospital mortality.
-
Dronedarone was significantly more effective than placebo in maintaining sinus rhythm and in reducing the ventricular rate during recurrence of arrhythmia.
-
When used in conjunction with clinical and radiographic data, brain natriuretic peptide levels may provide a non-invasive alternative for distinguishing between ARDS and cardiogenic pulmonary edema in patients with severe hypoxemic respiratory failure.
-
Carcinoma of unknown primary remains a management problem without an established approach demonstrated to prolong survival. In a phase II study, the combination of carboplatin, gemcitabine, and capecitabine was shown to be fairly well tolerated and, for certain subsets, effective in producing transient tumor regression.
-
Withdrawal of statin therapy in acute ischemic stroke may lead to increases in death and disability.
-
The US FDA Adverse Event Reporting System (AERS) was searched for reports of nephrolithiasis in HIV patients receiving atazanavir (ATV)-containing antiretroviral (ARV) regimens; 30 cases were identified.
-
Long-term monitoring is likely to detect atrial fibrillation in stroke patients with frequent atrial premature beats.
-
Outcomes for treatment of stroke with intravenous tissue plasminogen activator (tPA) were similar at community hospitals supported by telemedicine consultation with stroke experts compared to academic stroke centers.